Moreover, other intracellular proteins have been positively evaluated as targets for immunotherapy: alpha-synuclein in a mouse model for Parkinson's disease [63] and superoxide dismutase in an ALS mouse model [64]. This evidence concerns the gene SNCA and Parkinson disease.